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Introduction 
The ageing process in mammals is complex and is often accom-
panied by a number of  chronic and acute pathologies whose in-
cidence increases with age. Moreover life events can impact sub-
stantially on both the ageing process itself  and on the incidence 
and impact to the individual of  the medical conditions, and a 
number of  conditions can be influenced by lifestyle factors such 
as diet and exercise. Sub-optimal diet has been linked to a large 
proportion of  the global burden of  disease [1]. If  clinical con-
ditions can be alleviated by non-pharmacological interventions 
such as a change in diet, as is the case for Type II diabetes [2-4], 
a significant cost saving could be made in sustaining an ageing 
population.
Over the course of  evolution mechanisms have developed that 
allow individuals to withstand periods of  nutritional deficiency, 
and this has been discussed elsewhere [5]. However, in developed 
countries in the present day the more common problem is one of  
nutrient over-availability, and changed patterns of  food consump-
tion have led to an obesity epidemic in the human population and 
an increase in the incidence of  conditions such as diabetes, coro-
nary heart disease and joint disease, all of  which impact signifi-
cantly on quality of  life. Such diseases are no longer thought of  as 
diseases of  old age, since they are increasingly prevalent in much 
younger age groups. We and others have studied the effects of  
diet on markers of  disease [6-9]. Rats are frequently used in such 
research because they bring all the benefits of  a well-understood 
laboratory model, and are not fussy eaters. Rats are also subject to 
many deleterious effects of  ageing, and long-term studies using 
rats reveal the gradual onset of  age-related pathologies.
The experimental diet that we have used here models the kind 
of  sub-optimal diet that is increasingly eaten in affluent coun-
tries: it is high in fat and low in protein and fibre compared to 
an optimal control diet. The two diets used here are equivalent 
in carbohydrate content, but the high fat content of  the Western 
affluent diet makes it more energy-dense than the control diet, 
which is a chow made by the same manufacturer but optimised 
for rodent maintenance [10]. In addition to cardiovascular prob-
lems [11], high-fat diets of  this kind are known to promote the 
development of  fatty liver disease and other metabolic abnormali-
ties [8], to affect the structure of  the kidney [12], and to affect the 
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performance of  the immune system [13]. All of  these parameters 
are important for the development of  chronic health conditions, 
and at a population level there is interest in identifying specific 
biomarkers that can be used to predict the onset of  cardiovascu-
lar, hepatic and renal pathologies, and hence to manage the risks 
associated with them.
Here we describe a study undertaken to investigate two questions: 
first, whether a Western affluent diet affects long-term health in 
the rat, and second, to what extent early changes in blood bio-
markers can predict specific pathologies. This information could 
be used to predict future illness so that dietary or other interven-
tions may be made before the clinical onset of  the disease. In 
order to be a reliable predictor a biomarker must be linked to a 
known abnormality, and must be detectable above background 
level at a time before the abnormality has become a clinical prob-
lem.
In this study we examined the gross morphology of  target organs, 
and levels of  biochemical markers used clinically for the diagnosis 
of  cardiovascular, liver and kidney abnormalities. To address our 
first question we compared the prevalence of  pathologies in a 
control population eating an optimal diet with that in a population 
eating a high fat, low protein Western affluent diet. To address 
the second question we examined the profile of  blood biomark-
ers in these two groups at three time points: weaning, 12 months 
and 18 months of  age. We sought biomarkers that showed small 
changes at the 12 month time point and larger changes at the 18 
month time point, and that could be linked to an increased level 
of  particular pathologies.
Materials and Methods
Animals
Animals were male Sprague-Dawley rats, bred in-house and main-
tained in an enriched environment on a 14h light: 10h dark cycle. 
Animals were kept and treated in accordance with the UK Ani-
mals (Scientific Procedures) Act, 1986, and the experiments were 
approved by the Open University Animal Welfare and Ethics Re-
view Board. Rats were caged in Scantainers (Scanbur Technology, 
Denmark) at ambient temperature (19-23˚C) and 50 ± 10% hu-
midity. They were given cardboard tubes and aspen wood blocks 
(LBS Biotechnology, UK). Rats were weaned at three weeks old 
directly onto the experimental or control diets, which were avail-
able ad libitum, and were maintained at two littermates per cage 
until the age of  12 months or 18 months, when they were used. 
During this period each rat was weighed weekly until 5 months 
of  age and monthly thereafter, and examined visually for signs 
of  ill-health. Because the rats were given wood blocks to gnaw, 
no dental problems were encountered. Growth curves for the 
animals are shown in Figure 1a. Hepatomegaly is frequently as-
sociated with high-fat diets [14], but Figure 1b shows that in this 
study the size of  the liver remained in proportion to body mass 
across all the animal groups. All animals were harvested at the 
same time of  day, 5 hours into the light phase. A total of  35 rats 
were used in this study. Seven weanlings were used as controls; 
these animals were assumed to be in optimal dietary conditions 
although not necessarily representative of  older, weaned animals 
eating an optimum diet. At each time point (12 months and 18 
months) 4 animals eating the control diet and 10 animals eating 
the experimental diet were harvested. The reason for the smaller 
number of  control animals is that we already have substantial data 
on such animals [8, 14] and for ethical reasons did not wish to 
repeat this data collection needlessly.
Diets
The control diet was RM3 and the experimental diet was Western 
RD (WRD), both purchased from Special Diet Services, With-
am, Essex, UK. The components of  both diets, taken from the 
manufacturer’s data [10], are shown in Table 1. It can be seen that 
the principal differences between the diets are the content of  fat 
(higher in WRD) and protein (lower in WRD). WRD is also lower 
in fibre and ash, suggesting that this diet may be less able to sup-
port gut function. The carbohydrate components of  the two diets 
are equivalent, but the WRD is more energy-dense, as estimated 
from the Atwater Fuel Energy calculation [15].
Sampling
At the time of  harvest, rats were weighed then deeply anaesthe-
tised with Isofane (Novartis Animal Health UK Ltd). Approxi-
mately 4 ml of  blood was obtained by cardiac puncture. Following 
coagulation at room temperature the clots were spun down and 
the supernatants were removed and stored at –80°C until analysis. 
Immediately following cardiac bleeding, the rats were killed by in-
tracardiac injection of  Pentoject (Animal Care Ltd, UK). Organs 
were then removed for visual assessment of  size, shape, colour 
and the presence of  any gross abnormalities such as ulcers or 
tumours. They were not routinely assessed histologically. Organs 
removed for examination were brain, heart, stomach, intestines, 
liver, pancreas, spleen and kidneys.
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Figure 1. (a) Growth of  rats eating the control (closed symbols) or experimental (open symbols) diet over the period from 
weaning to 18 months of  age; (b) relationship between the liver mass and whole body mass in animals at the time of         
harvest.
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Biochemical analyses
Serum metabolites, electrolytes, renal profile, liver profile and lipid 
profile were measured using a Cobas Integra 800 analyser (Roche 
Diagnostics, Mannheim, Germany). The analytes tested are listed 
in Table 2. Sera from the same animals were also used in triplicate 
in ELISAs to determine circulating levels of  insulin. All ELISA 
assays were carried out using the Alpco Insulin (rat) ultrasensitive 
ELISA kit (Stratech Scientific Ltd, Newmarket, UK).
Statistical analyses
Data are expressed as mean ± SEM. Differences between means 
were assessed by ANOVAs and t-tests as appropriate, using Prism 
v5 (GraphPad Software, San Diego, California, USA, www.graph-
pad.com). Since sample sizes were small and unequal, and had 
unequal variances (with the variances being greater in the larger 
experimental diet groups) ANOVA cannot detect small but sig-
nificant differences, and it is recommended to use t-tests for ana-
lysing these data [16]. Differences were considered statistically 
significant at the P < 0.05 level. Relative risk was calculated from 
the equation:
Relative risk = probability of  disease in rats eating WRD/prob-
ability of  disease in rats eating RM3.
Results and Discussion
Animal health
Rats are commonly used in dietary studies because they are not 
fussy eaters and are physiologically robust [17]. In this study we 
observed the health status of  rats eating one of  two diets, and at 
three time points. We measured the levels of  standard biochemical 
markers used diagnostically, and related them to the pathologies 
that we observed. We were particularly looking at a population 
level for biochemical markers that showed significant changes by 
18 months on a sub-optimal diet and which also showed a lesser 
change in the same direction at 12 months on the diet, such that 
the marker could be used clinically in a predictive way to allow 
early therapeutic interventions.
A number of  gross pathologies were observed when the ani-
mals were harvested. At the start of  the experiment all rats were 
healthy and active, with good coats and general appearance. One 
rat eating the control diet and one eating the WRD had to be 
culled before 12 months due to poor health. Two further rats eat-
ing the experimental WRD were found dead in their cages be-
tween 12 and 18 months. These four animals were omitted from 
the analysis. Among the animals which survived until the experi-
mental end-point, 4 out of  13 rats harvested at 12 months, and 7 
out of  11 rats harvested at 18 months were found to have one or 
more pathologies upon dissection in spite of  appearing in good 
health judging by coat condition, food intake and activity. Overall, 
12.5% of  animals eating the RM3 diet (all ages) had an overt pa-
thology, compared with 56.3% of  those eating the WRD (33.3% 
at 12 months and 85.7% at 18 months; see Table 3). This means 
that over the course of  the study the relative risk of  developing a 
pathology was 4.5 times higher for rats eating the WRD than for 
those eating the RM3 diet.
Table 3 also shows that all but one of  the animals exhibiting 
pathologies had levels of  specific biomarkers either elevated or 
depressed beyond one standard deviation from the population 
mean. The specific analyte changes were consistent with the ob-
served pathologies; for example kidney abnormalities were ac-
companied by changes in creatinine and urea levels in the blood. 
This indicates that the analytes used do indeed reflect particu-
lar health problems. These results clearly demonstrate that rats 
can appear to be healthy while nevertheless harbouring a variety 
of  pathologies, and provide further evidence that a sub-optimal 
Western affluent diet cannot support long-term health.
Biochemical analysis
Following biochemical analysis, the majority of  analytes showed 
no differences between the cohorts of  animals eating the two di-
ets or at the ages examined. These analytes included C-reactive 
protein, a marker of  immune function, so in this study we were 
unable to detect any changes in the immune status of  the animals. 
Statistically significant changes were, however, observed in the 
following analytes: iron, ALT, AST, albumin, creatinine, choles-
terol, HDL-cholesterol, TAG, cortisol, glucose and insulin. We 
detail these differences below.
Iron: Compared with the level seen at weaning, iron levels de-
creased with age, and were significantly lower (P < 0.01) in 18 
month old animals compared with weanlings (Figure 2a). There 
were no significant differences between the diets. This was the 
only change observed in serum electrolytes, in contrast to previ-
ous work that showed a reduction in potassium level with age [8], 
and this may be accounted for by the different diets used in these 
two studies.
Cortisol: Corticosterone, not cortisol (which is measured by the 
clinical analyser) is the primary glucocorticoid stress hormone 
in the rat; nevertheless cortisol measurements can be used as a 
proxy measurement for stress as there is considerable overlap in 
the values for the two hormones [18]. There was a slight but not 
significant upward trend in cortisol in WRD animals compared to 
those eating the RM3 diet (Figure 2b). Levels of  glucocorticoid 
Special Issue on "Dietary patterns and health risks"
Table 1. Components of  the diets used in this study (from manufacturer’s data).
RM3 WRD
Fat (% w/w) 4.2 21.4
Protein (% w/w) 22.45 17.5
Fibre (% w/w) 4.42 3.5
Ash (% w/w) 8.05 4.1
Carbohydrate (% w/w) 50.4 50.0
Energy (kcal/g) 3.29 4.63
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stress hormones have been reported to rise with age in the rat [19] 
and we also observed this trend, although the rise was not statisti-
cally significant. However we found that cortisol levels were high 
in weanlings compared with the other groups (Figure 2b). Similar 
findings have been reported by others, and this effect is thought 
to be a response to the stress of  weaning [20].
Markers of  liver function: ALT rose with age (RM3 diet) but 
dropped in the WRD animals (Figure 2c). This pattern was also 
seen to a lesser extent with AST (not shown). The significant drop 
in 18 month WRD animals (P < 0.001) was accompanied by a 
non-significant but consistent decrease at 12 months; thus ALT 
is a possible candidate for a disease biomarker, although it may 
be an imprecise marker since low ALT was associated with an 
atrophied brain, ulcerated kidney and stomach, and leukocytosis 
(Table 3). Albumin remained stable in the RM3 animals, but there 
was a highly significant drop (P < 0.001) in the WRD animals at 
18 months which was not seen at 12 months (Figure 2d). Liver 
enzymes are frequently used as clinical markers of  a range of  con-
ditions, and we have previously found a number of  changes with 
age and diet in Sprague-Dawley rats [8, 14]. Although in humans 
an enlarged liver is frequently associated with ill-health, we did 
not observe this phenomenon, and all the livers remained in the 
correct proportion to whole body mass (Figure 1b). A histological 
examination of  some of  the livers (not shown) showed glycogen 
and fatty deposits increasing with age, and noticeably more prom-
inent with animals eating the high-fat diet, consistent with our 
previous findings and those of  others [14, 21]. In this study we 
observed that the rise in AST and ALT with age seen in control 
animals was substantially abolished in WRD animals, which also 
showed a significant drop in levels of  albumin at 18 months (Fig-
ure 2c and d; P < 0.001). These results suggest a profound change 
in the liver metabolism of  WRD animals that can be linked to 
general ill-health (as revealed by the pathology data) but not to 
any specific condition.
Markers of  kidney function: In view of  the number of  kidney 
abnormalities that we observed post-mortem we anticipated that 
there would be changes in the levels of  the kidney markers that 
we used, particularly since levels of  these markers are known to 
vary with the protein content of  the diet [22]. Across the experi-
mental groups there were no changes in levels of  urea (Figure 
2e). Mean creatinine levels did not change with age in the RM3 
animals, but increased with age in the WRD animals (Figure 2f). 
Individual rats with kidney abnormalities had elevated creatinine 
levels compared with normal members of  their cohort (Table 3), 
accounting for the significant rise in the mean value (and SEM) 
seen in the 18 month WRD group. This suggests that, in addi-
tion to its current diagnostic use [3], creatinine could be used in a 
predictive way to allow early therapeutic intervention for kidney 
abnormalities. Based on these data, further study of  creatinine 
expression during disease development is warranted.
Lipid profiles: Blood lipids are well known as markers of  ill-
health, and are particularly linked to cardiovascular disease. In 
these experiments total cholesterol increased in the control an-
imals between weaning and 12 months of  age (P < 0.05), but 
remained stable thereafter. The WRD 12 month group had a 
similar cholesterol level to the RM3 group, but at 18 months the 
mean had increased to a highly significant level (P < 0.001; Figure 
2g). In these studies LDL cholesterol remained fairly stable (not 
shown) but the HDL cholesterol showed an interesting pattern. 
In the control RM3 rats HDL cholesterol increased significant-
ly by 12 months, but this increase was completely abolished in 
the WRD animals at both 12 and 18 months (Figure 2h). This 
was not unexpected, given the fat content of  the WRD (Table 
1). The consequence of  this change was that the total choles-
terol: HDL-cholesterol ratio showed significant changes with diet, 
with the 12 month value being a good predictor of  the 18 month 
value (Figure 2i). Likewise, whereas the control animals showed a 
non-significant increase in TAG level at 12 months compared to 
weanlings that then remained stable, the WRD animals showed a 
significant rise (P < 0.01) at 18 months that was predicted by the 
12 month pattern (Figure 2j). A separately conducted multivariate 
analysis of  volatile organic compounds in the faeces of  the same 
animals [23] also suggested that TAG, total cholesterol, and the 
total cholesterol : HDL-cholesterol ratio could be reliably used as 
predictive markers.
Glucose and insulin: As noted above, the animals in this study 
were fed ad libitum, and all were harvested at the same time in the 
dark-light cycle. The carbohydrate content of  the two diets was 
similar (Table 1), so in spite of  the raised body mass and increased 
blood lipid markers exhibited by the WRD animals (Figures 1a 
and 2g-j) there was no increase in circulating glucose levels. In fact 
by 18 months in both control and experimental animals blood 
glucose levels were significantly lower (P < 0.001) than at weaning 
and 12 months (Figure 3a).
An unexpected result was found when we examined the levels 
of  circulating insulin. It has been shown in several species in-
cluding the rat that circulating insulin levels rise with increasing 
glucose intake [24] and insulin levels are linked to diabetes. We 
observed no rise in insulin levels with either age or diet, and given 
Table 2: Analytes investigated in this study and their clinical significance. AP, alkaline phosphatase; AST, aspartate ami-
notransferase; ALT, alanine aminotransferase; GGT, γ - glutamyl transferase; HDL, high density lipoprotein; LDL, low 
density lipoprotein; TAG, triacylglycerol; CRP, C-reactive protein.
Serum electrolytes Kidney function Liver function Lipid profile Other analytes
Sodium Urea Albumin Cholesterol Glucose
Potassium Creatinine Bilirubin HDL-cholesterol Insulin
Calcium AP LDL-cholesterol CRP
Magnesium AST TAG Oestradiol
Phosphate ALT Testosterone
Iron GGT Cortisol
Transferrin
Ferritin
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Figure 3. Circulating insulin and glucose in all groups of  rats. (a) circulating glucose levels in all groups of  rats; (b) insulin 
levels in control (closed symbols) or experimental (open symbols) groups; (c) two populations of  insulin secretors; (d) rela-
tionship between circulating glucose and insulin levels; (e) relationship between levels of  insulin and levels of  lipid mark-
ers; (f) relationship between insulin levels and body mass at the time of  harvest. *** P < 0.001.
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the carbohydrate content of  the two diets noted above this was 
not surprising. However, insulin values fell over a wide range in 
all the cohorts, and the spread of  values seen was similar regard-
less of  age or diet (Figure 3b). Careful examination of  the data 
revealed that no values fell between 0.7 and 0.9 ng/ml, suggest-
ing that there were two insulin-secreting phenotypes: one giving 
values in the range 0.2 to 0.7 ng/ml (mean 0.35 ng/ml), and the 
other giving values in the range 0.9 to 2.3 ng/ml (mean 1.4 ng/
ml). These populations were significantly different by t-test (P < 
0.001; Figure 3c). Differences in insulin levels were not associated 
with changes in glucose levels (Figure 3d), nor was there any cor-
relation between insulin level and the level of  any lipid markers 
(Figure 3e), terminal body mass (Figure 3f), or any specific gross 
pathology (Table 3). We consider it unlikely that the high values 
represent a post-prandial increase since rats are trickle feeders and 
do not exhibit the pattern of  insulin secretion found in humans. 
The mean value exhibited by the higher population (1.4 ng/ml)
is similar though slightly higher than that reported for baseline 
circulating insulin by others: 1 ng/ ml [24] or 1.09 ng/ml [25]. The 
mean lower value (0.35 ng/ml) is slightly below the range of  0.4-
0.8 ng/ml reported for rats starved for 24 hours [25], but it should 
be noted that the rats in our study had not been starved and may 
just naturally exhibit a lower baseline circulating level. As far as 
we are aware this is the first report of  different insulin secreting 
phenotypes in unstressed Sprague-Dawley rats.
Conclusion
This study focused on two questions: first, whether a Western af-
fluent diet affects long-term health in the rat, and second, whether 
early changes in blood biomarkers can predict specific patholo-
gies. The first question has an unequivocal answer, in that the 
health of  animals eating this diet was notably worse than that of  
animals eating a control, optimised diet, as measured by gross pa-
thologies observed post-mortem. The relative risk was 4.5 over the 
course of  the study.
Regarding the second question, we have found limited feasibility 
for using known biomarkers as predictors of  future disease, at 
least in the Sprague-Dawley rat. Five markers: HDL cholesterol, 
total cholesterol: HDL cholesterol (driven by the change in HDL 
cholesterol), triacylglycerols, ALT and creatinine clearly show a 
suitable pattern of  change. The changes for these markers are 
consistent and statistically significant, although it is unclear at pre-
sent whether they correlate with specific pathologies, and more 
work is required to confirm this. Our data bring together studies 
of  individual animals in which biomarker analysis can be correlat-
ed with specific health status, and cohort studies in which trends 
can be more easily identified. Future work in this area should use 
longitudinal studies with repeated sampling from the same ani-
mals.
We also report a previously unrecognised phenotypic diversity in 
insulin production by Sprague-Dawley rats.
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Table 3. Abnormalities observed post-mortem, and changes in biomarkers in these animals.
Experimental 
group
Number 
surviving to 
end point
Number with 
gross pathology
Observed pathology Biomarker abnormality (outside 
±1 SD)
Weanling 7 1 Mottled liver, malformed spleen High ALT
12 mo RM3 4 0
12 mo WRD 9 3 1. Stomach ulcer
2. Kidney tumour
3. Right side of  brain atrophied
1. None
2. High creatinine, urea, cholesterol,  
    testosterone
3. High TAG; Low ALT, testosterone
18 mo RM3 4 1 Abnormal diaphragm (? congenital) High ALT
18 mo WRD 7 6 1. Adrenal tumour; abnormal liver
    and pancreas
2. Ulcerated kidney and stomach
3. Tumour in ileum
4. Abnormal kidney and adrenal
    gland
5. Leukocytosis
6. Leukocytosis
1. High AST, magnesium
2. High creatinine, urea, phosphate, 
magnesium, cortisol; Low ALT, AST, 
testosterone
3. High AST
4. High creatinine, urea, calcium, 
magnesium, cholesterol, TAG, corti-
sol; Low albumin, iron
5. High cholesterol: HDL, TAG, cor-
tisol; Low ALT, albumin, AST
6. High calcium, cholesterol, TAG
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